253 related articles for article (PubMed ID: 29313713)
1. Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y
Russo JJ; James TE; Ruel M; Dupuis JY; Singh K; Goubran D; Malhotra N; Rubens F; Chong AY; Hibbert B; Boland P; Tran DT; Tanguay JF; Lordkipanidzé M; Perrault L; Wells GA; Bourke M; Chan V; So DY
Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):543-553. PubMed ID: 29313713
[TBL] [Abstract][Full Text] [Related]
2. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting.
Holm M; Biancari F; Khodabandeh S; Gherli R; Airaksinen J; Mariscalco G; Gatti G; Reichart D; Onorati F; De Feo M; Santarpino G; Rubino AS; Maselli D; Santini F; Nicolini F; Zanobini M; Kinnunen EM; Ruggieri VG; Perrotti A; Rosato S; Dalén M
Ann Thorac Surg; 2019 Jun; 107(6):1690-1698. PubMed ID: 30898561
[TBL] [Abstract][Full Text] [Related]
3. Impact of Ticagrelor Versus Clopidogrel on Bleeding Outcomes of Isolated Coronary Artery Bypass Grafting.
Ingrassia JJ; Mosleh W; Conner CM; Mather JF; Loya DS; Yaffee DW; Sutton TS; Takata ET; McMahon SR; Hashim SW; McKay RG
Cardiovasc Revasc Med; 2023 Jan; 46():44-51. PubMed ID: 35961855
[TBL] [Abstract][Full Text] [Related]
4. Precatheterization Use of P2Y
Badri M; Abdelbaky A; Li S; Chiswell K; Wang TY
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939715
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Held C; Asenblad N; Bassand JP; Becker RC; Cannon CP; Claeys MJ; Harrington RA; Horrow J; Husted S; James SK; Mahaffey KW; Nicolau JC; Scirica BM; Storey RF; Vintila M; Ycas J; Wallentin L
J Am Coll Cardiol; 2011 Feb; 57(6):672-84. PubMed ID: 21194870
[TBL] [Abstract][Full Text] [Related]
6. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
7. Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.
Brilakis ES; Held C; Meier B; Cools F; Claeys MJ; Cornel JH; Aylward P; Lewis BS; Weaver D; Brandrup-Wognsen G; Stevens SR; Himmelmann A; Wallentin L; James SK
Am Heart J; 2013 Sep; 166(3):474-80. PubMed ID: 24016496
[TBL] [Abstract][Full Text] [Related]
8. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.
Hansson EC; Jidéus L; Åberg B; Bjursten H; Dreifaldt M; Holmgren A; Ivert T; Nozohoor S; Barbu M; Svedjeholm R; Jeppsson A
Eur Heart J; 2016 Jan; 37(2):189-97. PubMed ID: 26330426
[TBL] [Abstract][Full Text] [Related]
10. Preoperative clopidogrel and outcomes in patients with acute coronary syndrome undergoing coronary artery bypass surgery.
Qu J; Zhang D; Zhang H; Rao C; Chen S; Zhao Y; Zheng Z
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1044-1052.e15. PubMed ID: 32444184
[TBL] [Abstract][Full Text] [Related]
11. Safety and Effectiveness of Contemporary P2Y
Yun JE; Kim YJ; Park JJ; Kim S; Park K; Cho MS; Nam GB; Park DW
J Am Heart Assoc; 2019 Jul; 8(14):e012078. PubMed ID: 31310570
[TBL] [Abstract][Full Text] [Related]
12. How Do Type of Preoperative P2Y
Voetsch A; Pregartner G; Berghold A; Seitelberger R; Schoerghuber M; Toller W; Mahla E
Ann Thorac Surg; 2021 Jan; 111(1):77-84. PubMed ID: 32565086
[TBL] [Abstract][Full Text] [Related]
13. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Ebrahimi R; Dyke C; Mehran R; Manoukian SV; Feit F; Cox DA; Gersh BJ; Ohman EM; White HD; Moses JW; Ware JH; Lincoff AM; Stone GW
J Am Coll Cardiol; 2009 May; 53(21):1965-72. PubMed ID: 19460609
[TBL] [Abstract][Full Text] [Related]
14. The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y
O'Donoghue ML; Murphy SA; Sabatine MS
Circulation; 2020 Aug; 142(6):538-545. PubMed ID: 32551860
[TBL] [Abstract][Full Text] [Related]
15. Preoperative treatment with clopidogrel and ticagrelor on bleeding complications in off-pump coronary artery bypass grafting.
Wang Z; Li X; Ye Y; Xia L; Zou Y; Xu Q; Yao Y; Li X; Lv Q
Thromb Res; 2022 Nov; 219():70-76. PubMed ID: 36126565
[TBL] [Abstract][Full Text] [Related]
16. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
Whellan DJ; Tricoci P; Chen E; Huang Z; Leibowitz D; Vranckx P; Marhefka GD; Held C; Nicolau JC; Storey RF; Ruzyllo W; Huber K; Sinnaeve P; Weiss AT; Dery JP; Moliterno DJ; Van de Werf F; Aylward PE; White HD; Armstrong PW; Wallentin L; Strony J; Harrington RA; Mahaffey KW
J Am Coll Cardiol; 2014 Mar; 63(11):1048-57. PubMed ID: 24211500
[TBL] [Abstract][Full Text] [Related]
17. Comparison of major bleeding in patients with acute coronary syndrome that underwent coronary artery bypass grafting treated with clopidogrel or ticagrelor: a systematic review and meta-analysis.
Rohman MS; Purnamasari Y; Ilmawan M; Mahdi BA; Tamara F; Mahendra AI; Mazen M; Heriansyah T; Yamin M; Pikir BS; Fajar JK
F1000Res; 2020; 9():99. PubMed ID: 33732438
[No Abstract] [Full Text] [Related]
18. Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database.
Sirker A; Kwok CS; Kontopantelis E; Johnson T; Freeman P; de Belder MA; Ludman P; Zaman A; Mamas MA
Catheter Cardiovasc Interv; 2018 Oct; 92(4):659-665. PubMed ID: 29356278
[TBL] [Abstract][Full Text] [Related]
19. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative.
Faridi KF; Garratt KN; Kennedy KF; Maddox TM; Secemsky EA; Butala NM; Yeh RW
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e006275. PubMed ID: 32156164
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis.
Vuilliomenet T; Gebhard C; Bizzozero C; Glauser S; Blum S; Buser A; Bolliger D; Grapow MTR; Siegemund M
Interact Cardiovasc Thorac Surg; 2019 May; 28(5):665-673. PubMed ID: 30535154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
